| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.66B | 12.86B | 14.19B | 12.95B | 10.35B |
| Gross Profit | 4.40B | 4.78B | 5.35B | 4.96B | 4.34B |
| EBITDA | 4.72B | 5.15B | 5.51B | 5.03B | 4.42B |
| Net Income | 1.07B | 1.53B | 1.86B | 1.89B | 1.69B |
Balance Sheet | |||||
| Total Assets | 65.89B | 63.24B | 61.16B | 57.06B | 47.04B |
| Cash, Cash Equivalents and Short-Term Investments | 4.78B | 5.30B | 7.64B | 7.17B | 4.94B |
| Total Debt | 25.64B | 25.22B | 25.24B | 23.54B | 19.14B |
| Total Liabilities | 44.02B | 41.79B | 39.79B | 36.58B | 30.13B |
| Stockholders Equity | 13.17B | 12.79B | 12.99B | 12.97B | 10.51B |
Cash Flow | |||||
| Free Cash Flow | 149.70M | -2.36B | -948.69M | -166.82M | -1.02B |
| Operating Cash Flow | 3.39B | 2.78B | 3.68B | 3.88B | 2.84B |
| Investing Cash Flow | -2.87B | -5.43B | -4.11B | -4.21B | -3.98B |
| Financing Cash Flow | -438.20M | 605.35M | 1.87B | 2.58B | -518.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$576.01M | 1.91 | 6.27% | 6.03% | 4.85% | -4.80% | |
70 Outperform | HK$1.73B | 1.83 | 2.82% | ― | 3.04% | 6.91% | |
69 Neutral | HK$648.34M | 3.87 | 3.62% | ― | -9.45% | -17.46% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
64 Neutral | HK$52.17B | 3.97 | 8.14% | 4.96% | -37.73% | 13.53% | |
63 Neutral | HK$8.16B | 4.22 | 6.61% | 5.22% | -9.02% | -39.00% | |
60 Neutral | HK$27.84B | 13.49 | 5.58% | 6.48% | 9.77% | -0.62% |